Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter

Journal of Lipid Research

Volumn 39, Issue 5, 1998, Pages 969-977

  Hoppe, Kenneth L ^a   Francone, Omar L ^a  

^a PFIZER INC   (United States)

Author keywords

LCAT; Sp1; Sp3; Transcriptional regulation

Indexed keywords

HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; DROSOPHILA; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELLS, CULTURED; DNA; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROMOTER REGIONS (GENETICS); SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; SUPPRESSION, GENETIC; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 0031923603     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Warden, C. H., C. A. Langner, J. I. Gordon, B. A. Taylor, J. W. McLean, and A. J. Lusis. 1989. Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin:cholesterol acyltransferase gene: evidence for expression in brain and testes as well as liver. J. Biol. Chem. 264: 21573-21581.
2. Francone, O. L., A. Gurakar, and C. Fielding. 1989. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J. Biol Chem. 264: 7066-7072.
3. Fielding, C. J., V. G. Shore, and P. E. Fielding. 1972. A protein co-factor of lecithin:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46: 1493-1498.
4. Francone, O. L., and C. J. Fielding. 1991. Structure-function relationships in human lecithin:cholesterol acyltransferase. Site-directed mutagenesis at serine residues 181 and 216. Biochemistry. 30: 10074-10077.
5. Kuivenhoven, J. A., H. Pritchard, J. Hill, J. Frohlich, G. Assmann, and J. Kastelein. 1997. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38: 191-205.
6. Vaisman, B. L., H. G. Klein, M. Rouis, A. M. Berard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. Hoyt, Jr., S. M. Marcovina, J. J. Albers, J. M. Hoeg, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1995. Overexpression of human lecithin:cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275.
7. Mehlum, A., B. Staels, N. Duverger, A. Tailleux, G. Castro, C. Fievet, G. Luc, J-C. Fruchart, G. Olivecrona, G. Skretting, J. Auwerx, and H. Prydz. 1995. Tissue-specific expression of the human gene for lecithin:cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile. Eur. J. Biochem. 230: 567-575.
8. Francone, O. L., E. L. Gong, D. S. Ng, C. J. Fielding, and E. M. Rubin. 1995. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effect of human apolipoprotein A-I and human apolipoprotein A-II on plasma lipoprotein cholesterol metabolism. J. Clin. Invest. 96: 1440-1448.
9. Francone, O. L., M. Haghpassand, J. A. Bennett, L. Royer, and J. McNeish. 1997. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. J. Lipid Res. 38: 813-822.
10. Hoeg, J. M., B. L. Vaisman, S. J. Demosky, Jr., S. M. Meyn, G. D. Talley, R. F. Hoyt, Jr., S. Feldman, A. M. Berard, N. Sakai, D. Wood, M. E. Brousseau, S. Marcovina, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1996. Lecithin:cholesterol acyltransferase overexpression generates hyperalphalipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 271: 4396-4402.
11. Hengstschlager-Ottnad, E., K. Kuchler, and W. J. Schneider. 1995. Chicken lecithin:cholesterol acyltransferase: molecular characterization reveals unusual structure and expression pattern. J. Biol. Chem. 270: 26139-26145.
12. Ly, H., O. L. Francone, C. J. Fielding, J. K. Shigenaga, A. H. Moser, C. Grunfeld, and K. R. Feingold. 1995. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J. Lipid Res. 36: 1254-1263.
13. Staels, B., A. van Tol, G. Skretting, and J. Auwerx. 1992. Lecithin:cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates. J. Lipid Res. 33: 727-735.
14. Tjian, R., and T. Maniatis. 1994. Transcriptional activation: a complex puzzle with few easy pieces. Cell. 77: 5-8.
15. Larsen, F., J. Solheim, T. Kristensen, A. B. Kolsto, and H. Prydz. 1993. A tight cluster of five unrelated human genes on chromosome 16q22.1. Hum. Mol. Genet. 2: 1589-1595.
16. Meroni, G., N. Malgaretti, M. Pontoglio, S. Ottolenghi, and R. Taramelli. 1991. Functional analysis of the human lecithin:cholesterol acyl transferase gene promoter. Biochem. Biophys. Res. Commun. 180: 1469-1475.
17. Courey, A. J., and R. Tjian. 1988. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55: 887-898.
18. Kingsley, C., and A. Winoto. 1992. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12: 4251-4261.
19. Rosenthal, N. 1987. Indentification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152: 704-720.
20. Schneider, I. 1972. Cell lines derived from late embryonic stages of Drosophila melanogaster. J. Embryol. Exp. Morphol. 27: 353-365.
21. Di Nocera, P. P., and I. B. Dawid. 1983. Transient expression of genes introduced into cultured cells of Drosophia. Proc. Natl. Acad. Sci. USA. 80: 7095-7098.
22. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
23. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19: 2499.
24. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
25. Courey, A. J., and R. Tjian. 1992. Mechanisms of transcriptional control as revealed by studies of human transcription factor Sp1. In Transcriptional Regulation. S.L. McKnight and K.R. Yamamoto. editors. Cold Spring Harbor Laboratory Press, Plainview, NY. 743-769.
26. Hagen, G., S. Muller, M. Beato, and G. Suske. 1992. Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res. 20: 5519-5525.
27. Kennett, S. B., A. J. Udvadia, and J. M. Horowitz. 1997. Sp3 encodes multiple proteins that differ in their capacity to stimulate of repress transcription. Nucleic Acids Res. 25: 3110-3117.
28. Hagen, G., S. Muller, M. Beato, and G. Suske. 1994. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13: 3843-3851.
29. Birnbaum, M. J., A. J. van Wijnen, P. R. Odgren, T. J. Last, G. Suske, G. S. Stein, and J. L. Stein. 1995. Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry. 34: 16503-16508.
30. Gidoni, D., J. T. Kadonaga, H. Barrera-Saldana, K. Takahashi, P. Chambon, and R. Tjian. 1985. Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science. 230: 511-517.
31. Kadonaga, J. T., K. A. Jones, and R. Tjian. 1986. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem. 11: 20-23.
32. Bucher, P. 1990. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212: 563-578.
33. Conn, K. J., C. B. Rich, D. E. Jensen, M. R. Fontanilla, M. M. Bashir, J. Rosenbloom, and J. A. Foster. 1996. Insulin-like growth factor-I regulates transcription of the elastin gene through a putative retinoblastoma control element: a role for Sp3 acting as a repressor of elastin gene transcription. J. Biol. Chem. 271: 28853-28860.
34. Smith, K. M., R. M. Lawn, and J. N. Wilcox. 1990. Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rehesus monkey tissues by in situ hybridization. J. Lipid Res. 31: 995-1004.
35. Saffer, J. D., S. P. Jackson, and M. B. Annarella. 1991. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11: 2189-2199.
36. Persengiev, S. P., P. J. Raval, S. Rabinovitch, C. F. Millette, and D. L. Kilpatrick. 1996. Transcription factor Sp1 is expressed by three different developmentally regulated messenger ribonucleic acids in mouse spermatogenic cells. Endocrinology. 137: 638-646.
37. Minie, M. E., T. Kimura, and G. Felsenfeld. 1992. The developmental switch in embryonic rho-globin expression is correlated with erythroid lineage-specific differences in transcription factor levels. Development. 115: 1149-1164.
38. Merchant, J. L., A. Shiotani, E. R. Mortensen, D. K. Shumaker, and D. R. Abraczinskas. 1995. Epidermal growth factor stimulation of the human gastrin promoter requires Sp1. J. Biol. Chem. 270: 6314-6319.
39. Jackson, S. P. and R. Tjian. 1988. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell. 55: 125-133.
40. Han, I., and J. E. Kudlow. 1997. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17: 2550-2558.
41. Armstrong, S. A., D. A. Barry, R. W. Leggett, and C.R. Mueller. 1997. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272: 13489-13495.
42. Hoey, T., R. O. J. Weinzierl, G. Gill, J. L. Chen, B. D. Dynlacht, and R. Tjian. 1993. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell. 72: 247-260.
43. Mastrangelo, I. A., A. J. Courey, J. S. Wall, S. P. Jackson, and P. V. C. Hough. 1991. DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. USA. 88: 5670-5674.
44. Lee, Y. H., M. Yano, S. Y. Liu, E. Matsunaga, P. F. Johnson, and F. J. Gonzalez. 1994. A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor. Mol. Cell. Biol. 14: 1383-1394.
45. Talianidis, I., A. Tambakaki, J. Toursounova, and V. I. Zannis. 1995. Complex interactions between SP1 bound to multiple distal reglatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene. Biochemistry. 34: 10298-10309.
46. Sanchez, H. B., L. Yieh, and T. F. Osborne. 1995. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270: 1161-1169.
47. Yieh, L., H. B. Sanchez, and T. F. Osborne. 1995. Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter. Proc. Natl. Acad. Aci. USA. 92: 6102-6106.
48. Gillen, C. M., S. Brill, J. A. Payne, and B. Forbush, III. 1996. Molecular cloning and functional expression of the K-C1 cotransporter from rabbit, rat, and human: a new member of the cation-chloride cotransporter family. J. Biol. Chem. 271: 16237-16244.